PriceTargets.com logo

PACS Group - PACS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $30.50
  • Forecasted Upside: 24.39%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$24.52 As of 05/7/2024 02:27 PM ET
▼ -0.41 (-1.64%)

This chart shows the closing price for PACS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PACS Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PACS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PACS

Analyst Price Target is $30.50
▲ +24.39% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for PACS Group in the last 3 months. The average price target is $30.50, with a high forecast of $32.00 and a low forecast of $27.00. The average price target represents a 24.39% upside from the last price of $24.52.

This chart shows the closing price for PACS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in PACS Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/14/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/12/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/11/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/7/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/7/2024

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2024StephensInitiated CoverageOverweight$31.00Low
5/6/2024JPMorgan Chase & Co.Initiated CoverageOverweight$27.00Low
5/6/2024CitigroupInitiated CoverageBuy$32.00Low
5/6/2024OppenheimerInitiated CoverageOutperform$31.00Low
5/6/2024Truist FinancialInitiated CoverageBuy$32.00Low
5/6/2024Royal Bank of CanadaInitiated CoverageOutperform$30.00Low
(Data available from 5/7/2019 forward)

News Sentiment Rating

0.57 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/10/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/9/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/9/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/8/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/7/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/8/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/7/2024
  • 15 very positive mentions
  • 24 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
5/7/2024

Current Sentiment

  • 15 very positive mentions
  • 24 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

PACS Group

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Read More

Today's Range

Now: $24.52
Low: $24.42
High: $25.13

50 Day Range

MA: N/A

52 Week Range

Now: $24.52
Low: $22.61
High: $25.72

Volume

85,975 shs

Average Volume

644,321 shs

Market Capitalization

$3.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of PACS Group?

The following Wall Street sell-side analysts have issued stock ratings on PACS Group in the last twelve months: Citigroup Inc., JPMorgan Chase & Co., Oppenheimer Holdings Inc., Royal Bank of Canada, Stephens, and Truist Financial Co..
View the latest analyst ratings for PACS.

What is the current price target for PACS Group?

6 Wall Street analysts have set twelve-month price targets for PACS Group in the last year. Their average twelve-month price target is $30.50, suggesting a possible upside of 24.4%. Truist Financial Co. has the highest price target set, predicting PACS will reach $32.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $27.00 for PACS Group in the next year.
View the latest price targets for PACS.

What is the current consensus analyst rating for PACS Group?

PACS Group currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PACS will outperform the market and that investors should add to their positions of PACS Group.
View the latest ratings for PACS.

What other companies compete with PACS Group?

Other companies that are similar to PACS Group include The Ensign Group, RadNet, CymaBay Therapeutics, Integer and Insmed. Learn More about companies similar to PACS Group.

How do I contact PACS Group's investor relations team?

PACS Group's physical mailing address is 262 North University Avenue, Farmington, UT 84025, United States. The company's listed phone number is 801-447-9829 and its investor relations email address is [email protected]. The official website for PACS Group is pacs.com. Learn More about contacing PACS Group investor relations.